Pancreatic Cancer Research

Clinical trialNo phase (not a drug trial)Suspended

RCT of Mobile Apps & FitBit v. Usual Care

Randomized Clinical Trial of FitBit and Mobile Apps Versus Usual Care to Improve Post-Operative Outcomes After GI Cancer Surgery

Outcome
Stopped earlyStudy is paused for interim analysis. (Other)
Phase
No phase (not a drug trial)
Status
Suspended
Study type
Interventional
Start
31 May 2017
Expected end
March 2027
Enrollment
107 participants
Sites
1
Primary outcomes
Readmission rate
Sponsor type
Academic / other
Results posted
No
Last update
28 September 2026

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

This is a randomized clinical trial to evaluate the use of mobile devices in preventing readmission in patients undergoing major GI cancer operations.

Detailed description public domain (ClinicalTrials.gov)

Patients will be randomized to 1) standard of care or 2) to use our mobile app with standard care. The mobile app will collect information on patients' daily physical activity patterns and health status data for clinicians using smartphone mobile technology applications. The investigators believe that by tracking information on patients, the investigators may be able to intervene sooner and prevent a delay in care.